by Adrienne Berard, Pennsylvania State University The biomarker cascade in AD starts with amyloid beta pathology. This leads to amyloid-related tau pathology, neuronal dysfunction/loss and subsequent cognitive impairment. Credit: PLOS Computational Biology (2022). DOI: 10.1371/journal.pcbi.1010481 An estimated 6.2 million Americans ages 65 and older are living with Alzheimer’s disease. The national Alzheimer’s Association predicts that number to grow to...
